Further, in pre-clinical models of MPNST we confirm that inhibiting SHH pathway in MPNST-G1 prevent growth and malignant progression, providing the rational for investigating these treatments in clinical trials. This evidence concerns the gene SHH and malignant peripheral nerve sheath tumor.